Identifying genetic factors linked to oxidative stress in age-related macular degeneration.
Identification of the specific risk allele responsible for oxidative stress in ARMS2/HTRA1-related AMD
This study is looking at how certain genes might affect oxidative stress in age-related macular degeneration (AMD) by creating special models of aging eye cells, which could help find better treatments for AMD and similar eye conditions.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10912592 on NIH RePORTER |
What this research studies
This research aims to identify specific genetic variations that contribute to oxidative stress in age-related macular degeneration (AMD). By utilizing CRISPR technology, the team will create patient-specific models that mimic the aging process in retinal cells, allowing for a better understanding of how these genetic factors influence the disease. The approach involves pharmacologically aging cells to replicate the conditions found in older adults, which may lead to more effective interventions. Ultimately, this research seeks to uncover potential therapeutic targets for AMD and other related conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who are at risk for or have been diagnosed with age-related macular degeneration.
Not a fit: Patients with other unrelated eye conditions or those under 21 years old may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that specifically target the genetic causes of age-related macular degeneration.
How similar studies have performed: While the application of CRISPR in this specific context is novel, similar genetic approaches have shown promise in other areas of research.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Tsang, Stephen H — Columbia University Health Sciences
- Study coordinator: Tsang, Stephen H
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.